TipRanks
Go Ultimate55% OFF

Tevogen Bio Holdings (G280) Cash flow

Tevogen Bio Holdings Cash Flow

DE:G280's free cash flow for Q2 2026 was $-3.01M. For the 2026 fiscal year, DE:G280's free cash flow was increased by $3.00 and operating cash flow was $-3.01M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Mar 25Mar 24Dec 22Dec 21
$ -12.33M$ -12.00M$ -8.17M$ -8.66M$ -5.27M
$ -64.44K$ 0.00$ -133.00K$ -479.04K$ -109.73K
$ 11.66M$ 12.23M$ 3.87M$ 7.50M$ 12.50M
$ 552.37K$ 1.28M$ 1.05M$ 5.48M$ 7.12M
$ -12.39M$ -12.00M$ -8.30M$ -9.13M$ -5.38M

Currency in USD

Tevogen Bio Holdings Cash Flow

-15M-10M-5M05M10M15M20212022202320242025OperatingInvestingFinancing